Post by The Medical Educator Consortium (MEC), Inc

What is the Best Systemic Therapy for Advanced Esophageal Cancer? Dr. David H. Ilson, MD, PhD, Medical Oncologist, Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center (New York, NY), presented a comprehensive review of current systemic therapy strategies for advanced esophagogastric cancer at the MATOS GI Edition (Masters in Therapeutic Oncology Summit) — covering biomarker-driven testing (HER2, MSI, PD-L1, Claudin 18.2), NCCN-endorsed chemotherapy regimens, and the latest data on HER2-targeted therapy and immunotherapy combinations in the metastatic setting. Program Directors: Mitesh J. Borad, MD Professor of Medicine, Mayo Clinic College of Medicine and Science Getz Family Professor of Research at Mayo Clinic Arizona Scottsdale, AZ Mike Cusnir, MD The Pulver Family Division Chief of Hematology and Oncology Co-Director, GI Cancer Program Mount Sinai Medical Center, Comprehensive Cancer Center Miami Beach, FL Presented in partnership with The Medical Educator Consortium. www.mymedflix.com is the premier educational platform for oncology content for healthcare professionals. #MATOSGI #OncologyEducation #GICancer #EsophagealCancer #PrecisionOncology #MedEd Edgardo S. Santos, MD, FACP, FASCO Luis E Raez Teri Valls, CMP, CMM Lowell Anthony Mike Cusnir Richard Kim Rutika Mehta Sarbajit Mukherjee, MD, MS Philip Agop Philip

Video Content